PRE-clinical investigation of AT7519, a novel CDK inhibitor, as a potential therapeutic agent in pancreatic cancer

✍ Scribed by Thomas, A.; Shaw, E.; Ghaneh, P.; Greenhalf, W.; Davies, M.; Costello, E.; Gibbs, F.; Lyons, J.; Sibson, D.R.; Neoptolemos, J.P.

• Book ID: 122568067
• Publisher: S. Karger AG
• Year: 2012
• Tongue: English
• Weight: 45 KB
• Volume: 12
• Category: Article
• ISSN: 1424-3903
• DOI: 10.1016/j.pan.2012.03.023